Navis Wealth Advisors’s VanEck Biotech ETF BBH Stock Holding History

Navis Wealth Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$752K	Hold	3,998	–	–	0.38%	71
2025 Q4	$757K	Buy	3,998 +20	+0.5%	+$3.7K	0.32%	75
2025 Q3	$659K	Hold	3,978	–	–	0.49%	43
2025 Q2	$610K	Hold	3,978	–	–	0.51%	41
2025 Q1	$626K	Hold	3,978	–	–	0.61%	38
2024 Q4	$624K	Buy	3,978 +31	+0.8%	+$5.21K	0.68%	33
2024 Q3	$700K	Hold	3,947	–	–	0.76%	31
2024 Q2	$665K	Hold	3,947	–	–	0.76%	29
2024 Q1	$657K	Hold	3,947	–	–	0.79%	29
2023 Q4	$653K	Buy	3,947 +17	+0.4%	+$2.62K	0.85%	23
2023 Q3	$612K	Hold	3,930	–	–	0.89%	21
2023 Q2	$613K	Hold	3,930	–	–	0.56%	26
2023 Q1	$637K	Hold	3,930	–	–	0.7%	26
2022 Q4	$628K	Buy	3,930 +18	+0.5%	+$2.85K	0.89%	24
2022 Q3	$551K	Hold	3,912	–	–	0.85%	25
2022 Q2	$570K	Hold	3,912	–	–	0.61%	36
2022 Q1	$634K	Hold	3,912	–	–	0.56%	44
2021 Q4	$741K	Buy	3,912 +8	+0.2%	+$1.54K	0.62%	37
2021 Q3	$789K	Hold	3,904	–	–	0.55%	44
2021 Q2	$787K	Hold	3,904	–	–	0.66%	37
2021 Q1	$685K	Buy	3,904 +1,065	+38%	+$193K	0.53%	45
2020 Q4	$482K	Buy	+2,839	New	+$468K	0.44%	50

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Navis Wealth Advisors's BBH Position: Q1 2026 in Review

Navis Wealth Advisors held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 3,998 shares worth $752K. The position accounts for 0.38% of the portfolio, ranked #71.

Navis Wealth Advisors first reported a position in BBH in Q4 2020 and has held it in 22 quarters since. The position peaked at $789K in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Navis Wealth Advisors held 3,998 shares of VanEck Biotech ETF worth $752K as of Q1 2026.
Navis Wealth Advisors left its VanEck Biotech ETF share count unchanged in Q1 2026.
VanEck Biotech ETF made up 0.38% of Navis Wealth Advisors's portfolio in Q1 2026, its #71 holding.
Navis Wealth Advisors first reported a position in VanEck Biotech ETF in Q4 2020 and has held it in 22 quarters since.
Navis Wealth Advisors's VanEck Biotech ETF position peaked at $789K in Q3 2021.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Navis Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.